MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagle, J. A.
Right arrow Articles by Shaw, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagle, J. A.
Right arrow Articles by Shaw, L. M.
Molecular and Cellular Biology, November 2004, p. 9726-9735, Vol. 24, No. 22
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.22.9726-9735.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis

Julie A. Nagle,1,{dagger} Zhefu Ma,1,{dagger} Maura A. Byrne,1 Morris F. White,2 and Leslie M. Shaw1*

Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School,1 Division of Endocrinology, Howard Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts2

Received 31 December 2003/ Returned for modification 5 March 2004/ Accepted 26 August 2004

The insulin receptor substrate (IRS) proteins are adaptor molecules that integrate signals generated by receptors that are implicated in human breast cancer. We investigated the specific contribution of IRS-2 to mammary tumor progression using transgenic mice that express the polyoma virus middle T antigen (PyV-MT) in the mammary gland and IRS-2-null (IRS-2–/–) mice. PyV-MT-induced tumor initiation and growth were similar in wild-type (WT) and IRS-2–/– mice. However, the latency and incidence of metastasis were significantly decreased in the absence of IRS-2 expression. The contribution of IRS-2 to metastasis is intrinsic to the tumor cells, because IRS-2–/– mammary tumor cells did not metastasize when grown orthotopically in the mammary fat pads of WT mice. WT and IRS-2–/– tumors contained similar numbers of mitotic cells, but IRS-2–/– tumors had a higher incidence of apoptosis than did WT tumors. In vitro, IRS-2–/– mammary tumor cells were less invasive and more apoptotic in response to growth factor deprivation than their WT counterparts. In contrast, IRS-1–/– tumor cells, which express only IRS-2, were highly invasive and were resistant to apoptotic stimuli. Collectively, our findings reveal an important contribution of IRS-2 to breast cancer metastasis.


* Corresponding author. Mailing address: Department of Pathology, Beth Israel Deaconess Medical Center RN227, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-1430. Fax: (617) 975-5531. E-mail: lshaw{at}bidmc.harvard.edu.

{dagger} J.A.N. and Z.M. contributed equally.


Molecular and Cellular Biology, November 2004, p. 9726-9735, Vol. 24, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.22.9726-9735.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.